Author:adminTime:2019/12/5 21:15:38Click:1987
October 10, 2019 / Bio Valley BIOON /-Janssen Pharmaceuticals, a Johnson & Johnson subsidiary, recently announced that it has submitted a new supplement to the US Food and Drug Administration (FDA) depression drug Spravato (esketamine) CIII nasal spr····
Author:adminTime:2019/12/5 21:14:04Click:1993
On March 5, local time, the FDA issued a statement saying it agreed to approve the launch of a new nasal spray drug, Spravato (Esketamine), for the treatment of resistant depression. This is the first major depression treatment to enter the US market····
Author:adminTime:2019/11/28 9:27:35Click:2017
How to cross the blood-brain barrier is a challenge for drug developers. Now, after a new drug delivery test on locusts, a team of engineers showed how aerosol nasal sprays containing nanogold provide a non-invasive and fast way to deliver drugs to t····
Author:adminTime:2019/11/28 8:55:12Click:1850
Butorphin tartrate nasal spray, a quantitative spray to the nasal cavity for viscous administration, is an aqueous solution of butorphin tartrate. Each bottle of Butorphin tartrate nasal spray contains 2.5 ml of 10 mg / ml Butorphin tartrate solution····